The second scientific conference on proliferative blood cancers and myelodysplastic syndromes opened Saturday in Kuwait, drawing hematology experts, researchers, and specialists from both Kuwait and abroad. The event, organized by the Kuwait Leukemia and Lymphoma Society in collaboration with the Ministry of Health and Jaber Al-Ahmad Al-Sabah Hospital, focuses on recent advances in blood cancer treatment and research.

The Ministry of Health emphasized the conference’s role in aligning with rapid developments in hematology and leukemia research, aiming to strengthen the integration between scientific investigation and clinical practice. This integration is intended to enhance the quality of healthcare services delivered to patients affected by these diseases.

Speaking on behalf of Health Minister Dr. Ahmad Al-Awadhi, Assistant Undersecretary for Public Health Dr. Al-Mundhir Al-Hasawi highlighted the significance of such specialized gatherings in facilitating the exchange of expertise and encouraging evidence-based medical practices. He noted that the discussions and scientific interactions at the conference contribute to generating recommendations for the advancement of healthcare services and patient care.

Dr. Al-Hasawi also pointed out the growing emphasis in modern medicine on precision medicine and targeted therapies. These approaches involve tailoring treatments to individual patients by considering the genetic and molecular characteristics of their diseases. He explained that this strategy can improve the effectiveness of therapy, minimize side effects, and ultimately lead to better health outcomes.

Furthermore, he stressed that the evolving medical perspective not only focuses on achieving favorable laboratory results but also prioritizes comprehensive patient care. Success is increasingly measured by reductions in complications, symptom relief, and improvements in patients’ overall quality of life. The conference aims to foster collaboration and knowledge sharing to support these objectives in blood cancer treatment.